Intelligent Medicines Trademark Published for Opposition
Summary
The United States Patent and Trademark Office (USPTO) has published the trademark application for "INTELLIGENT MEDICINES" for opposition. The application covers goods and services related to peptides, nucleotides, medicinals, and regenerative medicine.
What changed
The USPTO has published the trademark application TM99505408, "INTELLIGENT MEDICINES," for a 30-day opposition period. The application, filed on November 19, 2025, seeks to register the mark for goods and services including peptides, nucleotides, medicinals, and regenerative medicine.
This publication signifies a step in the trademark registration process. Interested parties have until March 22, 2026, to file an opposition. If no opposition is filed, the trademark will proceed to registration. Companies operating in the pharmaceutical and biotechnology sectors should be aware of this publication if they have similar marks or are considering using "Intelligent Medicines" or related terms.
What to do next
- Monitor trademark opposition period for "INTELLIGENT MEDICINES" ending March 22, 2026.
Source document (simplified)
← USPTO Trademark Applications
INTELLIGENT MEDICINES
Published for Opposition TM99505408 Kind: published Mar 22, 2026
Abstract
Peptides, Nucleotides, Medicinals, and Regenerative Medicine.
Filing Date
2025-11-19
Related changes
Source
Classification
Who this affects
Taxonomy
Browse Categories
Get Pharma & Drug Safety alerts
Weekly digest. AI-summarized, no noise.
Free. Unsubscribe anytime.
Get alerts for this source
We'll email you when ChangeBridge: Trademarks - Pharmaceuticals (Class 005) publishes new changes.